Back
NovaBay Pharmaceuticals Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
35
NBY
NovaBay Pharmaceuticals
Last Price:
$0.56
Seasonality Move:
-0.66%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
NovaBay Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.53 | Buy |
| 20-day SMA: | 0.56 | Sell |
| 50-day SMA: | 0.63 | Sell |
| 200-day SMA: | 1.84 | Sell |
| 8-day EMA: | 0.53 | Buy |
| 20-day EMA: | 0.57 | Sell |
| 50-day EMA: | 0.63 | Sell |
| 200-day EMA: | 4.62 | Sell |
NovaBay Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 42.52 | Sell |
| Chaikin Money Flow: | 22882 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.53 - 0.65) | Sell |
| Bollinger Bands (100): | (0.49 - 0.69) | Sell |
NovaBay Pharmaceuticals Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NovaBay Pharmaceuticals Stock
Is NovaBay Pharmaceuticals Stock a Buy?
-
NovaBay Pharmaceuticals share price is 0.54 while NBY 8-day simple moving average is 0.53, which is a Buy signal.
-
The stock price of NBY is 0.54 while NovaBay Pharmaceuticals 20-day SMA is 0.56, which makes it a Sell.
-
NovaBay Pharmaceuticals 50-day simple moving average is 0.63 while NBY share price is 0.54, making it a Sell technically.
-
NBY stock price is 0.54 and NovaBay Pharmaceuticals 200-day simple moving average is 1.84, creating a Sell signal.
NBY Technical Analysis vs Fundamental Analysis
Sell
35
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy or a Sell?
-
NovaBay Pharmaceuticals stock is rated a SellThe current NovaBay Pharmaceuticals [NBY] share price is $0.54. The Score for NBY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
NovaBay Pharmaceuticals Stock Info
Market Cap:
2.6M
Price in USD:
0.54
Share Volume:
22.9K
NovaBay Pharmaceuticals 52-Week Range
52-Week High:
9.08
52-Week Low:
0.36
Sell
35
NovaBay Pharmaceuticals (NBY)
is a Sell
NovaBay Pharmaceuticals Share Price Forecast
-
What is the NovaBay Pharmaceuticals stock price today?The NovaBay Pharmaceuticals stock price is 0.54 USD today.
-
Will NBY stock go up or go down?NovaBay Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is NovaBay Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovaBay Pharmaceuticals is overvalued.
Is NovaBay Pharmaceuticals Stock a Buy?
-
NovaBay Pharmaceuticals share price is 0.54 while NBY 8-day exponential moving average is 0.53, which is a Buy signal.
-
The stock price of NBY is 0.54 while NovaBay Pharmaceuticals 20-day EMA is 0.57, which makes it a Sell.
-
NovaBay Pharmaceuticals 50-day exponential moving average is 0.63 while NBY share price is 0.54, making it a Sell technically.
-
NBY stock price is 0.54 and NovaBay Pharmaceuticals 200-day simple moving average is 4.62, creating a Sell signal.
Fundamental Analysis of NovaBay Pharmaceuticals
Is NovaBay Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Technical Analysis of NovaBay Pharmaceuticals
Should I short NovaBay Pharmaceuticals stock?
-
NBY Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting NovaBay Pharmaceuticals is a Sell
-
NovaBay Pharmaceuticals Relative Strength Index (RSI) is 42.52, which suggest NovaBay Pharmaceuticals is oversold
-
The Bollinger Bands (25) for NovaBay Pharmaceuticals is (0.53 - 0.65), which suggest NovaBay Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for NovaBay Pharmaceuticals is (0.49 - 0.69), which suggest NovaBay Pharmaceuticals is a Sell
* NovaBay Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.